A detailed history of Nisa Investment Advisors, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 5,939 shares of EOLS stock, worth $81,958. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,939
Previous 5,811 2.2%
Holding current value
$81,958
Previous $63,000 52.38%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$10.66 - $17.48 $1,364 - $2,237
128 Added 2.2%
5,939 $96,000
Q2 2024

Jul 19, 2024

BUY
$10.45 - $13.76 $20 - $27
2 Added 0.03%
5,811 $63,000
Q1 2024

May 01, 2024

BUY
$9.99 - $14.91 $419 - $626
42 Added 0.73%
5,809 $81,000
Q4 2022

Feb 02, 2023

BUY
$6.52 - $8.95 $110 - $152
17 Added 0.3%
5,767 $43,000
Q4 2021

Feb 03, 2022

BUY
$5.37 - $8.38 $27,924 - $43,576
5,200 Added 945.45%
5,750 $43,000
Q4 2020

Jan 25, 2021

BUY
$2.92 - $4.84 $1,606 - $2,662
550 New
550 $2,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $774M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.